DESIGN THERAPEUTICS INC (DSGN) Stock Balance Sheet
NASDAQ:DSGN - Nasdaq - US25056L1035 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 13.67M | 22.56M | 21.20M | 26.50M | 298.60M | |||
| Marketable Securities | 216.01M | 222.91M | 260.60M | 303.90M | 85.50M | |||
| Receivables | 1.41M | 1.26M | 1.43M | N/A | N/A | |||
| Other Current Assets | 2.57M | 1.30M | 1.35M | 4.70M | 1.40M | |||
| Total Current Assets | 234.00M | 248.00M | 285.00M | 335.10M | 385.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.40M | 3.63M | 4.63M | 5.60M | 5.10M | |||
| Other Non-Current Assets | 430.00K | 430.00K | 430.00K | 500.00K | 0.00 | |||
| Total Non-Current Assets | 3.00M | 4.00M | 5.00M | 6.00M | 5.20M | |||
| TOTAL ASSETS | 237.00M | 252.00M | 290.00M | 341.10M | 390.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 5.06M | 6.28M | 7.68M | 7.80M | 3.70M | |||
| Accounts Payable | 3.18M | 2.19M | 1.94M | 3.00M | 1.60M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 8.24M | 8.46M | 9.62M | 10.80M | 5.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.32M | 1.53M | 2.33M | 3.10M | 3.10M | |||
| Total Non-Current Liabilities | 1.32M | 1.54M | 2.38M | 3.00M | 3.10M | |||
| TOTAL LIABILITIES | 9.56M | 10.00M | 12.00M | 13.80M | 8.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -245.00M | -227.00M | -178.00M | -110.80M | -47.50M | |||
| Additional Paid In Capital | 472.00M | 469.00M | 455.00M | 441.40M | 429.80M | |||
| Common Shares | 10.00K | 10.00K | 10.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 450.00K | 480.00K | 60.00K | -3.40M | -200.00K | |||
| Shares Outstanding | 57.00M | 57.00M | 56.00M | 55.90M | 55.40M | |||
| Tangible Book Value per Share | 4.01 | 4.27 | 4.92 | 5.86 | 6.90 | |||
| Total Shareholders' Equity | 228.00M | 242.00M | 278.00M | 327.30M | 382.10M | |||
| TOTAL LIABILITIES AND EQUITY | 237.00M | 252.00M | 290.00M | 341.10M | 390.60M | |||
| Statistics | ||||||||
| Current Ratio | 28.40 | 29.31 | 29.63 | 31.03 | 72.72 | |||
| Return On Assets (ROA) | -24.05% | -19.84% | -23.10% | -18.56% | -9.10% | |||
| Return On Equity (ROE) | -25.00% | -20.66% | -24.10% | -19.34% | -9.30% | |||
All data in USD , ROIC based on taxRate of 0.21